Sodium Acetate Injection shortage
Current 15 presentations · 5 manufacturers · first FDA posting Feb 3, 2016 · last update Oct 15, 2026
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Milla Pharmaceuticals, Somerset Therapeutics, LLC
Stated reasons (per FDA): Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Next release November 2026. Check wholesalers for inventory. | Posted Mar 23, 2016 Updated Oct 15, 2026 |
| Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots will be available. Product will be made available as it is released. | Posted Feb 3, 2016 Updated Oct 14, 2026 |
| Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots will be available. Product will be made available as it is released. | Posted Feb 3, 2016 Updated Oct 14, 2026 |
| Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 3, 2016 Updated Oct 8, 2026 | |
| Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Other | Next Delivery: October 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay | Posted Feb 3, 2016 Updated Oct 8, 2026 |
| Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 3, 2016 Updated Oct 8, 2026 | |
| Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 3, 2016 Updated Oct 8, 2026 | |
| Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 3, 2016 Updated Oct 8, 2026 | |
| Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 3, 2016 Updated Oct 8, 2026 | |
| Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Milla Pharmaceuticals | Current Available |
— | Posted Feb 3, 2016 Updated Oct 15, 2026 | |
| Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Milla Pharmaceuticals | Current Available |
— | Posted Mar 23, 2016 Updated Oct 15, 2026 | |
| Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Milla Pharmaceuticals | Current Available |
— | Posted Mar 23, 2016 Updated Oct 15, 2026 | |
| Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Milla Pharmaceuticals | Current Limited Availability |
Other | Estimated recovery: TBD | Posted Feb 3, 2016 Updated Oct 15, 2026 |
| Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted Feb 3, 2016 Updated Sep 11, 2026 | |
| Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20) | Somerset Therapeutics, LLC | Current Available |
— | Posted Feb 3, 2016 Updated Sep 11, 2026 |